Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q2 2026: Novo Nordisk 12.087, Roche 17.5245.
* Roche reports semi-annually. Values are evenly split across both quarters within each half.
Novo Nordisk vs Roche: Revenue Comparison
Novo Nordisk (NVO) and Roche (RHHBY) are peers in GLP-1. Novo Nordisk reported revenue of $12.1B as of Q2 2026, compared with $35.0B for Roche. Roche leads on revenue.
Novo Nordisk's gross margin is 78.2% versus 73.7% for Roche. Novo Nordisk's net margin is 26.7% versus 22.6% for Roche.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Novo Nordisk, Roche.| Metric | Novo Nordisk | Roche |
|---|---|---|
| Market Cap | - | - |
| Revenue | $12.09B | $35.05B |
| Cost of Revenue | $2.63B | $9.21B |
| Gross Profit | $9.45B | $25.84B |
| Operating Income | $4.17B | $10.90B |
| Net Income | $3.23B | $7.93B |
| R&D Expense | $2.74B | $8.35B |
| Earnings Per Share | $0.73 | $1.23 |
| Gross Margin | 78.2% | 73.7% |
| Operating Margin | 34.5% | 31.1% |
| Net Profit Margin | 26.7% | 22.6% |
| Free Cash Flow | $6.53B | $6.46B |
| Cumulative Free Cash Flow | $107.39B | $305.80B |
| Operating Cash Flow | $8.50B | $8.28B |
| Cash & Equivalents | $6.85B | $6.13B |